Innoviva (INVA) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2025)
Innoviva (INVA) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Innoviva |
1.65 Bn |
1.05 Bn |
75.83 Mn |
| Date | Value |
|---|
| Sep 30, 2025 |
40.26% |
| Jun 30, 2025 |
204.05% |
| Sep 30, 2024 |
103.64% |
| Jun 30, 2024 |
-219.57% |
| Sep 30, 2023 |
4,800.00% |
| Jun 30, 2023 |
-95.24% |
| Sep 30, 2022 |
5,500.00% |
| Jun 30, 2022 |
-75.00% |
| Sep 30, 2021 |
0.00% |
| Jun 30, 2021 |
7.14% |
| Mar 31, 2021 |
71.43% |
| Dec 31, 2020 |
88.46% |
| Sep 30, 2020 |
-62.32% |
| Jun 30, 2020 |
16.95% |
| Mar 31, 2020 |
40.48% |
| Dec 31, 2019 |
16.67% |
| Sep 30, 2019 |
5.88% |
| Jun 30, 2019 |
9.68% |
| Mar 31, 2019 |
-86.75% |
| Dec 31, 2018 |
444.19% |
